UAE Clinical Trial Biorepository & Archiving Solutions Market Size & Outlook
UAE clinical trial biorepository & archiving solutions market, 2018-2030 (US$M)
Related Markets
UAE clinical trial biorepository & archiving solutions market highlights
- The UAE clinical trial biorepository & archiving solutions market generated a revenue of USD 5.2 million in 2023 and is expected to reach USD 10.3 million by 2030.
- The UAE market is expected to grow at a CAGR of 10.3% from 2024 to 2030.
- In terms of segment, biorepository services was the largest revenue generating service in 2023.
- Biorepository Services is the most lucrative service segment registering the fastest growth during the forecast period.
Clinical trial biorepository & archiving solutions market data book summary
| Market revenue in 2023 | USD 5.2 million |
| Market revenue in 2030 | USD 10.3 million |
| Growth rate | 10.3% (CAGR from 2023 to 2030) |
| Largest segment | Biorepository services |
| Fastest growing segment | Biorepository Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biorepository Services, Archiving Solution Services |
| Key market players worldwide | Azenta Inc, Thermo Fisher Scientific Inc, Precision for Medicine, Medpace Holdings Inc, Labcorp Drug Development, ATCC, Q2 Solutions, LabConnect, Charles River Laboratories International Inc |
Other key industry trends
- In terms of revenue, UAE accounted for 0.1% of the global clinical trial biorepository & archiving solutions market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa clinical trial biorepository & archiving solutions market is projected to lead the regional market in terms of revenue in 2030.
- Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 15.3 million by 2030.
Biorepository services was the largest segment with a revenue share of 65.38% in 2024. Horizon Databook has segmented the UAE clinical trial biorepository & archiving solutions market based on biorepository services, archiving solution services covering the revenue growth of each sub-segment from 2018 to 2030.
Growing prevalence of diabetes and cardiovascular diseases in the UAE is expected to increase the demand for treatment options, boosting the need for clinical trial studies for the same. Along with the presence of a vast patient pool, quicker and well-defined regulatory approval procedure in the country is expected to contribute to market growth.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Trial Biorepository & Archiving Solutions Market Scope
Clinical Trial Biorepository & Archiving Solutions Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UAE clinical trial biorepository & archiving solutions market size, by service, 2018-2030 (US$M)
UAE Clinical Trial Biorepository & Archiving Solutions Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
